30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Medtronic Company Profile

Revenue derived from spine and orthobiologics positions Medtronic as the fifth-largest in the orthopaedic industry. The company achieved sales of $2.9 billion in 2015.

Company Revenue, 1H16: A First Look

Our first look at 2Q16 revenue covers companies that reported in the month of July, with exhibits depicting where these companies stand at the half. 

NASS Preview: NASS Survey Finds Spine Professionals Independent and Influencing Decisions

In 2015, NASS conducted a survey taken by nearly 650 Members in the U.S. to support a clearer understanding of its Members’ practice settings.

NASS Preview: Growing Spine - International Markets, MIS and Product Portfolios

Eric Muehlbauer, Executive Director and CEO of NASS, sits in an interesting position in the spine industry in that he serves multiple stakeholders, from surgeons to device companies, to suppliers and service providers, around the globe. In speaking with him about NASS’ priorities, as well as where the greatest opportunities lie for surgeons and device companies, these three topics arose. 

NASS Preview: NASS Stresses a Proactive Approach to Drive Reimbursement in Spine

Surgeons and device companies face a similar challenge with reimbursement: it continues to be one of the greater barriers for technology adoption today due to payor pushback. With no foreseeable easement expected to come from private or public payors, surgeons and device companies must embrace a proactive approach.

Page Navigation